A Case of Prothionamide Induced Hepatitis on Patient with Multi-Drug Resistant Pulmonary Tuberculosis / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 251-256, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-169148
ABSTRACT
The prevalence of multi-drug resistant tuberculosis (MDR-TB), which is resistant to isoniazid and rifampin, has been increasing in Korea. And the side effects of 2nd line anti-tuberculosis medications, including drug-induced hepatitis, are well known. Although prothionamide (PTH) is one of the most useful anti-TB medications and although TB medication-induced acute hepatitis is a severe complication, there are only a few published case reports about prothionamide induced hepatitis. In this case report, a 22 year old male was diagnosed with pulmonary MDR-TB and was administered 2nd line anti-TB mediations, including PTH. Afterwards, he had a spiking fever and his liver enzymes were more than 5 times greater than the upper limit of the normal range. He was then diagnosed with drug-induced hepatitis by liver biopsy. His symptoms and liver enzyme elevation were improved after stopping PTH. Accordingly, we report this case of an association between PTH and acute hepatitis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Protionamida
/
Valores de Referencia
/
Rifampin
/
Tuberculosis Pulmonar
/
Biopsia
/
Prevalencia
/
Tuberculosis Resistente a Múltiples Medicamentos
/
Enfermedad Hepática Inducida por Sustancias y Drogas
/
Fiebre
/
Hepatitis
Tipo de estudio:
Estudio de prevalencia
Límite:
Humanos
/
Masculino
País/Región como asunto:
Asia
Idioma:
Coreano
Revista:
Tuberculosis and Respiratory Diseases
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS